Leonteq Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Leonteq Securities's VRTX Position: Q3 2026 in Review
Leonteq Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 75% in Q3 2026, selling an estimated $1.71M and leaving 1,090 shares worth $570K. The position accounts for 0.02% of the portfolio, ranked #320.
Leonteq Securities first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $7.52M in Q3 2021. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Leonteq Securities held 1,090 shares of Vertex Pharmaceuticals worth $570K as of Q3 2026.
- Leonteq Securities sold 3,343 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.71M.
- Vertex Pharmaceuticals made up 0.02% of Leonteq Securities's portfolio in Q3 2026, its #320 holding.
- Leonteq Securities first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's Vertex Pharmaceuticals position peaked at $7.52M in Q3 2021.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.